About Our Company
Davis Morgan LABS is an emerging, global pharmaceutical company with proven capabilities in the areas of product research, manufacturing & marketing. Over the years, Davis Morgan LABS has emerged as one of the fastest-growing Indian pharmaceutical companies. Our products are manufactured in the best-in-class manufacturing facilities that are WHO/GMP certified. We are an ISO 9001:2015 Certified Pharma Company. Our focus on specialty segments in India and simultaneous opening of newer markets abroad has helped us maintain the growth. We have firmly established our brands in each market for sustained sales. We have established strong capabilities in the international market with exports contributing a substantial part of the total revenues.
Davis Morgan LABS was incorporated in 1999 and has since moved up the value chain from being a small manufacturer to a vibrant marketing and research-oriented company. Davis Morgan LABS is now one of the leading pharmaceutical companies from India.
To become a leading global healthcare organization driven by people, research and technology
Contributing towards better healthcare through innovation. Maximizing value for our stakeholders and customers.
Our Product Portfoilo
DAVIS MORGAN LABS produces an absolute range of pharmaceutical formulation and health care assortments and our products consist of tablets ,capsules, syrups, topicals, Nasal or eye drops, and injections. Our product range comprises both generic pharmaceuticals as well as active pharmaceuticals. All of these health care assortments are developed as per WHO norms.
Research & Development
DAVIS MORGAN LABS R&D; efficiency plays a vital role for its complete business operations, as it offers a sustainable, long-term, and competitive benefit to the organization. There are strong R&D; facilities, that are contemplated and designed for both drug discovery and development. In addition to it, there is a number of scientists, who are engaged in several path-breaking researches. Davis Morgan LABS is committed to developing new technologies. We have been able to launch products with enhanced release profiles to ensure better treatment compliance and dosage convenience.